Lee Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,942
Closed -$99.6K – 239
2023
Q4
$99.6K Buy
1,942
+42
+2% +$2.21K 0.02% 178
2023
Q3
$110K Hold
1,900
– – 0.02% 156
2023
Q2
$122K Hold
1,900
– – 0.02% 151
2023
Q1
$132K Sell
1,900
-41
-2% -$2.89K 0.02% 150
2022
Q4
$140K Hold
1,941
– – 0.02% 170
2022
Q3
$138K Sell
1,941
-7
-0.4% -$508 0.03% 166
2022
Q2
$150K Buy
1,948
+21
+1% +$1.6K 0.03% 161
2022
Q1
$141K Sell
1,927
-208
-10% -$14K 0.03% 169
2021
Q4
$133K Buy
2,135
+1,550
+265% +$90.9K 0.03% 170
2021
Q3
$35K Buy
585
+85
+17% +$5.6K 0.01% 262
2021
Q2
$33K Hold
500
– – 0.01% 264
2021
Q1
$32K Buy
+500
New +$31.1K 0.01% 261
2020
Q4
– Sell
-164
Closed -$10K – 479
2020
Q3
$10K Sell
164
-2
-1% -$120 ﹤0.01% 396
2020
Q2
$10K Hold
166
– – ﹤0.01% 368
2020
Q1
$9K Hold
166
– – ﹤0.01% 309
2019
Q4
$11K Hold
166
– – ﹤0.01% 329
2019
Q3
$8K Hold
166
– – ﹤0.01% 374
2019
Q2
$8K Buy
166
+2
+1% +$93 ﹤0.01% 382
2019
Q1
$8K Hold
164
– – ﹤0.01% 363
2018
Q4
$9K Hold
164
– – ﹤0.01% 292
2018
Q3
$10K Sell
164
-246
-60% -$14.6K ﹤0.01% 322
2018
Q2
$23K Sell
410
-30
-7% -$1.62K 0.01% 326
2018
Q1
$27K Buy
440
+276
+168% +$17.8K 0.01% 313
2017
Q4
$10K Hold
164
– – ﹤0.01% 318
2017
Q3
$10K Hold
164
– – ﹤0.01% 325
2017
Q2
$9K Hold
164
– – ﹤0.01% 335
2017
Q1
$9K Sell
164
-600
-79% -$32.9K ﹤0.01% 284
2016
Q4
$45K Buy
+764
New +$41.8K 0.03% 183

Other funds holding BMY

Lee Financial's BMY Position: Q1 2024 in Review

Lee Financial sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 1,942 shares — an estimated $99.6K sold.

Lee Financial first reported a position in BMY in Q4 2016 and held it in 28 quarters. The position peaked at $150K in Q2 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Lee Financial reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 1,942 Bristol-Myers Squibb shares in Q1 2024, an estimated $99.6K.
  • Lee Financial first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 28 quarters.
  • Lee Financial's Bristol-Myers Squibb position peaked at $150K in Q2 2022.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.